Comparing two asthma inhalers for better symptom control
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study compares two common types of asthma inhalers to see which one works better for people with uncontrolled asthma. You may be able to join if you have asthma symptoms that are not well controlled.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 14 and 60 years old.
- You have been diagnosed with asthma and your symptoms are not well controlled.
- You do not have other lung conditions like COPD or interstitial lung disease.
- You do not have a fungal allergy or a condition called allergic bronchopulmonary aspergillosis.
- You do not have heart failure that causes asthma-like symptoms.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new combination inhaler works as well as a commonly used one for teenagers with asthma that is not well controlled. It aims to find a safe and effective treatment option for adolescents.
This study tests a new inhaler (PT027) against another inhaler (PT007) for teens aged 12 to 17 with asthma. It looks at how well the new inhaler works when used as needed, and if it is safe.
This study compares two versions of the common asthma rescue inhaler (salbutamol/albuterol) that use different propellants (the gas that pushes the medicine out). The goal is to see if the new propellant works as well as the current one. If you have mild asthma and are on a stable treatment plan, you may be able to join.
This study tests whether switching to a higher-dose or extrafine triple inhaler helps people whose asthma is still uncontrolled on their current medium-dose combination inhaler. It focuses on improving small-airway function, which may lead to better symptom control.
This study checks whether a new albuterol inhaler works the same way as a reference inhaler in adults with stable, mild asthma. It may help you (and others) by confirming that the inhaler delivers the right effect and is safe to use.
This trial tests whether a new inhaler (CHF5993) works as well as the current standard for adults with mild to moderate asthma. It compares how well the medicine controls asthma and opens airways.
Hear when a new Asthma (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.